An observational study in Influenza Vaccine, Papillomavirus Infection and Pertussis, sponsored by Duke University. Completed at 4 sites in United States. Open to female participants aged 12 Years to 26 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-10-16.
Sponsored by Duke University · Observational
PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases.
SPECIFIC AIMS
Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel \& office staff on their:
Determine the effectiveness of the vaccination program based on
495 studies on the registry are indexed under Papillomavirus Infections; 125 are open to participants now.
This study's enrollment of 3,988 is above the median of 400 across 147 observational studies indexed under Papillomavirus Infections.
Browse Papillomavirus Infections studies →Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.
Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Population Groups:
Adults
Minors
Patients
Pregnant Women
Fetuses
Inclusion Criteria:
Design \& implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, \& pertussis
Implementation and measurement of a health services intervention in community or private Ob/Gyn practices to improve the delivery of standard clinical care to vaccinate women against human papillomavirus, influenza, & pertussis.
Time frame: Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009.
This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke University